Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Updates on Immunotherapy and Immune Landscape in Renal Clear Cell Carcinoma
Myung‐Chul Kim, Jin Zeng, Ryan Kolb, et al.
Cancers (2021) Vol. 13, Iss. 22, pp. 5856-5856
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Heterogeneity in tertiary lymphoid structures predicts distinct prognosis and immune microenvironment characterizations of clear cell renal cell carcinoma
Wenhao Xu, Jiahe Lu, Wangrui Liu, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 12, pp. e006667-e006667
Open Access | Times Cited: 40
A novel endothelial-related prognostic index by integrating single-cell and bulk RNA sequencing data for patients with kidney renal clear cell carcinoma
Dengxiong Li, Qingxin Yu, Chui-Xuan Zeng, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 25
Unveiling the impact of tertiary lymphoid structures on immunotherapeutic responses of clear cell renal cell carcinoma
Wenhao Xu, Jiahe Lu, Xi Tian, et al.
MedComm (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 16
The cuproptosis-associated 13 gene signature as a robust predictor for outcome and response to immune- and targeted-therapies in clear cell renal cell carcinoma
Huiyang Yuan, Xin Qin, Jing Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 26
FRACTION-RCC: nivolumab plus ipilimumab for advanced renal cell carcinoma after progression on immuno-oncology therapy
Toni K. Choueiri, Harriet M. Kluger, Saby George, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 11, pp. e005780-e005780
Open Access | Times Cited: 26
Immune-Associated Gene Signatures Serve as a Promising Biomarker of Immunotherapeutic Prognosis for Renal Clear Cell Carcinoma
Qi Wang, Hanmin Tang, Xuehui Luo, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 24
MUC1 Drives the Progression and Chemoresistance of Clear Cell Renal Carcinomas
Emma Bourdon, Thomas Swierczewski, Marine Goujon, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 391-391
Open Access | Times Cited: 4
Single‐cell transcriptomic analysis in clear cell renal cell carcinoma: Deciphering the role of APP within the tumour microenvironment
Bo Guan, Ming O. Li, Di Cui, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 6
Open Access | Times Cited: 4
FDX1 expression predicts favourable prognosis in clear cell renal cell carcinoma identified by bioinformatics and tissue microarray analysis
Xing Huang, Tao Wang, Jiali Ye, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 18
Expression pattern of cancer-associated cellular senescence genes in clear cell renal cell carcinoma distinguishes tumor subclasses with clinical implications
Zhongxu Zhu, Qi Cao, Jie Chen, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Epigenetic regulation of macrophage function in kidney disease: New perspective on the interaction between epigenetics and immune modulation
Ruizhi Tan, Qianrong Bai, Lingfei Jia, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 183, pp. 117842-117842
Closed Access
Application of Immune Checkpoint Inhibitors in the Treatment of Renal Cell Carcinoma: Current Status, Challenges, and Future Directions
Lingxiang Ran, Rui Zhao, Li Yu, et al.
(2025) Vol. 1, Iss. 1, pp. 1-54
Closed Access
Revealing NAPSA’s role in ccRCC: Insights from single-cell RNA sequencing
Zhichao Li, Yuan Zhong, Dan Ye, et al.
Gene (2025), pp. 149478-149478
Closed Access
Autophagy-related gene LAPTM4B promotes the progression of renal clear cell carcinoma and is associated with immunity
He Wang, Qibo Wang, Yaoyao Wu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 9
Cuproptosis related gene PDHB is identified as a biomarker inversely associated with the progression of clear cell renal cell carcinoma
Hu Wang, Zhan Yang, Xingyu He, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 9
CD3+ and CD8+ T cell-based immune cell score as a prognostic factor in clear-cell renal cell carcinoma
Jonne Åkerla, Olli Helminen, Juha P. Väyrynen, et al.
Acta Oncologica (2024) Vol. 63, pp. 105-110
Open Access | Times Cited: 3
ANGPTL4 suppresses clear cell renal cell carcinoma via inhibition of lysosomal acid lipase
Zeng Jin, Umasankar De, Tanzia Islam Tithi, et al.
Cancer Research Communications (2024) Vol. 4, Iss. 8, pp. 2242-2254
Open Access | Times Cited: 3
Crosstalk between GBP2 and M2 macrophage promotes the ccRCC progression
Wei Zheng, Shujiang Ye, Bin Liu, et al.
Cancer Science (2024)
Open Access | Times Cited: 3
A Double-Negative Feedback Interaction between miR-21 and PPAR-α in Clear Renal Cell Carcinoma
Marine Goujon, J Woszczyk, Kelly Gaudelot, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 795-795
Open Access | Times Cited: 14
Integrated analysis of single-cell and bulk transcriptome identifies a signature based on NK cell marker genes to predict prognosis and therapeutic response in clear cell renal cell carcinoma
Ke Wang, M. Y. Yu, Zhouzhou Zhang, et al.
Translational Cancer Research (2023) Vol. 12, Iss. 5, pp. 1270-1289
Open Access | Times Cited: 8
Construction and validation of a chromatin regulator-related gene signature for prognostic and therapeutic significance of clear cell renal cell carcinoma
Changzheng Zhang, Jiayi Zeng, Chujin Ye, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 1, pp. 150-172
Open Access | Times Cited: 2
Cellular milieu in clear cell renal cell carcinoma
Arti M. Raghubar, Matthew J. Roberts, Simon Wood, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 10
MPP7 is a potential prognostic marker and is associated with cancer metabolism and immune infiltration in clear cell renal cell carcinoma: a bioinformatics analysis based on the TCGA database
Xiaowei Cheng, Ding Sun, Hao Li, et al.
Translational Andrology and Urology (2023) Vol. 12, Iss. 4, pp. 642-658
Open Access | Times Cited: 6
Potential prognostic and therapeutic value of ANXA8 in renal cell carcinoma: based on the comprehensive analysis of annexins family
Lihui Wang, Bo Cao, Yunlong Li, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Recent Advances in Single-Cell RNA-Sequencing of Primary and Metastatic Clear Cell Renal Cell Carcinoma
Adele M. Alchahin, Ioanna Tsea, Ninib Baryawno
Cancers (2023) Vol. 15, Iss. 19, pp. 4734-4734
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top